Atlas Trials

One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort Study

Clinical trial NCT03662919 · COMPLETED

Trial details

NCT number
NCT03662919
Sponsor
Biogen
Status
COMPLETED
Study type
OBSERVATIONAL
Arthritis, RheumatoidSpondylitis, AnkylosingArthritis, PsoriaticCrohn's DiseaseColitis, Ulcerative
Start date
2018-07-02
Primary completion
2022-06-30
Enrollment
2274

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.